Skip to content

Author

O. Kepp

We have 3 of 448 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Sep 2026

Cell death: immunogenic potential of cuproptosis in cancer

Recent data published in Cell demonstrate that a Cu 2+ -dependent form of regulated cell death (RCD) commonly known as cuproptosis is immunogenic, resulting in the emission of damage-associated molecular patterns (DAMPs) by malignant cells and the initiation of an adaptive anticancer immune response that not only ampli...

Lorenzo Galluzzi, O. Kepp, G. Kroemer · 0 citations
Open access Dec 2026

A novel oncolytic peptide synergizing with immunotherapy.

In a recent paper published in Nature, Yuan et al. described an acid-responsive membranolytic peptide that temporally separates lysosomes from later plasma membrane rupture, thereby converting oncolysis into immunogenic cell death. This elegant design permits systemic administration, elicits antigen-specific immunity,...

G. Kroemer, Xiao-Lian Deng, B. Sveinbjørnsson et al. · 0 citations
Open access Sep 2026

STAT3 inhibition for the induction of immunogenic cell death in multiple myeloma

It is reported that STAT3 inhibition eliminates multiple myeloma stem-like cells while eliciting hallmarks of immunogenic cell death, yet in vivo validation remains necessary before this strategy can be considered immunogenic.

O. Kepp, G. Kroemer · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.